Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report

Sorafenib is a multikinase inhibitor currently approved in Japan for the treatment of unresectable hepatocellular carcinoma. Interstitial pneumonia induced by sorafenib may have a fatal outcome, and therefore, has recently been the focus of many studies. The current report presents an autopsy case o...

Descripción completa

Detalles Bibliográficos
Autores principales: YAMAGUCHI, TAKASHI, SEKI, TOSHIHITO, MIYASAKA, CHIKA, INOKUCHI, RYOSUKE, KAWAMURA, RINAKO, SAKAGUCHI, YUUTAKU, MURATA, MIKI, MATSUZAKI, KOICHI, NAKANO, YORIKA, UEMURA, YOSHIKO, OKAZAKI, KAZUICHI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356407/
https://www.ncbi.nlm.nih.gov/pubmed/25789013
http://dx.doi.org/10.3892/ol.2015.2934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356407/
https://www.ncbi.nlm.nih.gov/pubmed/25789013
http://dx.doi.org/10.3892/ol.2015.2934

Ejemplares similares